Membership Growth and Retention - For the three months ended March 31, 2024, total approved members grew by 1% to 98,259 compared to 97,576 in the same period of 2023, driven by a 10% increase in Medicare approved members[131]. - The company implemented a retention strategy that includes updating the member onboarding experience and launching a loyalty program aimed at improving member retention[126]. - The company is focused on diversifying revenue streams and enhancing enrollment quality and member retention as part of its fiscal 2024 growth strategy[124]. - The company observed improvements in constrained lifetime values (LTV) across all Medicare-related plans, indicating better retention and conversion rates[125]. - The number of Medicare Advantage approved members increased by 9% to 65,750, while Medicare Supplement approved members rose by 35% to 6,182[131]. Financial Performance - Total revenue for the three months ended March 31, 2024, increased by $19.2 million, or 26%, to $92.964 million compared to $73.723 million in the same period in 2023[149]. - Commission revenue rose by $12.9 million, or 19%, driven by a 10% increase in overall Medicare plan approved members[150]. - Revenue from the Medicare segment increased by $20.6 million, or 33%, to $82.4 million for the three months ended March 31, 2024, compared to $61.8 million in the same period in 2023[173]. - The Medicare segment profit improved to $8.3 million for the three months ended March 31, 2024, compared to a loss of $0.6 million in the same period in 2023[175]. - Revenue from the Employer and Individual segment decreased by $1.3 million, or 11%, to $10.6 million for the three months ended March 31, 2024, compared to $11.9 million in the same period in 2023[176]. Expenses and Costs - Customer care and enrollment expenses increased by $7.8 million, or 31%, primarily due to a $5.8 million rise in personnel costs[157]. - Total acquisition cost per MA-equivalent approved member increased by $89, or 12%, to $834 compared to $745 in the same period in 2023[143]. - CC&E cost per MA-equivalent approved member rose by $70, or 20%, to $419, reflecting higher costs associated with benefit advisors[144]. - Variable marketing cost per IFP-equivalent approved member increased by $18, or 45%, to $58, driven by a decline in approved members[144]. - Marketing and advertising expenses increased by $5.9 million, or 18%, primarily due to a $4.0 million rise in variable advertising costs[155]. Cash Flow and Liquidity - Operating cash flow for the trailing twelve months as of March 31, 2024, was $3.3 million, exceeding the target of break-even cash flow for this period[127]. - The company had cash, cash equivalents, and short-term marketable securities of $188.9 million as of March 31, 2024, with operating cash flow of $70.8 million generated during the three months ended March 31, 2024[178]. - Net cash provided by operating activities was $70.8 million for the three months ended March 31, 2024, compared to $60.8 million for the same period in 2023[188][193]. - Cash and cash equivalents increased to $175.0 million as of March 31, 2024, up from $115.7 million as of December 31, 2023[203]. - Total cash, cash equivalents, short-term marketable securities, and restricted cash reached $192.0 million as of March 31, 2024, compared to $124.7 million at the end of the previous year[203]. Debt and Obligations - The company entered into a $70.0 million secured term loan credit facility, with an interest rate of 13.10% as of March 31, 2024, and incurred interest expenses of $2.3 million for the three months ended March 31, 2024[184][185]. - As of March 31, 2024, short-term obligations were $8.5 million for leases and $4.3 million for service and licensing, while long-term obligations were $29.8 million for leases and $0.6 million for service and licensing[181]. - The company issued 2,250,000 shares of Series A convertible preferred stock for an aggregate purchase price of $225.0 million, receiving $214.0 million in net proceeds[182]. Risk and Compliance - The company is exposed to credit risk from contracts with carriers, but considers this risk to be remote[204]. - Legal proceedings may affect the company's operations and financial condition, particularly regarding compliance with regulations[211]. - The company has not engaged in any foreign currency hedging or derivative transactions to date, despite exposure to foreign currency exchange risk[205]. - The company has not experienced material impacts from foreign currency fluctuations historically, but acknowledges potential future risks[205]. Operational Enhancements - The company has begun piloting updated co-browsing technology to enhance interactions between advisors and beneficiaries, expected to improve enrollment quality and sales efficiency[126]. - The company plans to maintain its internal telesales benefit advisors year-round and expects to increase their utilization by expanding ancillary product offerings[201]. - The company plans to resume enrollment growth in its E&I segment in the fourth quarter after implementing operational enhancements[141]. Tax and Financial Reporting - The effective tax rate decreased to 7.3% for the three months ended March 31, 2024, compared to 15.4% for the same period in 2023, primarily due to fluctuations in stock-based compensation adjustments and non-deductible expenses[167]. - Management believes that disclosure controls and procedures are effective, providing reasonable assurance for timely and accurate reporting[207]. - There were no changes in internal control over financial reporting that materially affected the company during the three months ended March 31, 2024[208].
eHealth(EHTH) - 2024 Q1 - Quarterly Report